Perrigo Company PLC (PRGO) EVP Buys $499,896.00 in Stock
Perrigo Company PLC (NYSE:PRGO) EVP Svend Andersen purchased 7,200 shares of Perrigo stock in a transaction dated Tuesday, August 14th. The shares were acquired at an average cost of $69.43 per share, for a total transaction of $499,896.00. The transaction was disclosed in a filing with the SEC, which is available through this link.
PRGO stock opened at $72.96 on Friday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.23 and a current ratio of 1.81. Perrigo Company PLC has a fifty-two week low of $67.53 and a fifty-two week high of $95.93. The company has a market cap of $9.56 billion, a P/E ratio of 14.80, a PEG ratio of 1.74 and a beta of 0.84.
Perrigo (NYSE:PRGO) last released its earnings results on Thursday, August 9th. The company reported $1.22 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.21 by $0.01. Perrigo had a net margin of 4.77% and a return on equity of 11.92%. The firm had revenue of $1.19 billion for the quarter, compared to analyst estimates of $1.23 billion. During the same period in the prior year, the firm earned $1.22 earnings per share. The business’s quarterly revenue was down 4.2% compared to the same quarter last year. analysts anticipate that Perrigo Company PLC will post 4.95 EPS for the current year.
PRGO has been the topic of several research reports. Cantor Fitzgerald set a $107.00 price target on shares of Perrigo and gave the stock a “buy” rating in a research report on Tuesday, May 8th. Wells Fargo & Co cut their target price on shares of Perrigo from $90.00 to $84.00 and set a “market perform” rating on the stock in a research note on Monday, May 14th. Canaccord Genuity set a $105.00 target price on shares of Perrigo and gave the stock a “buy” rating in a research note on Monday, May 14th. Royal Bank of Canada cut their target price on shares of Perrigo from $89.00 to $67.00 and set a “hold” rating on the stock in a research note on Friday, August 10th. Finally, Deutsche Bank lowered shares of Perrigo from a “buy” rating to a “hold” rating and cut their target price for the stock from $93.00 to $78.00 in a research note on Friday, August 10th. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and six have given a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $89.06.
A number of institutional investors have recently made changes to their positions in PRGO. Piedmont Investment Advisors LLC purchased a new position in Perrigo in the second quarter valued at approximately $110,000. Dupont Capital Management Corp increased its stake in Perrigo by 63.8% in the second quarter. Dupont Capital Management Corp now owns 1,705 shares of the company’s stock valued at $124,000 after purchasing an additional 664 shares during the last quarter. Twin Tree Management LP increased its stake in Perrigo by 271.0% in the first quarter. Twin Tree Management LP now owns 2,223 shares of the company’s stock valued at $185,000 after purchasing an additional 3,523 shares during the last quarter. Allianz Asset Management GmbH purchased a new position in Perrigo in the first quarter valued at approximately $205,000. Finally, Dynamic Technology Lab Private Ltd purchased a new position in Perrigo in the first quarter valued at approximately $208,000. Institutional investors own 80.89% of the company’s stock.
Perrigo Company Profile
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.